• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂时代睾丸癌幸存者的生活质量与激素紊乱

The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.

作者信息

Wiechno Paweł, Demkow Tomasz, Kubiak Krzysztof, Sadowska Małgorzata, Kamińska Janina

机构信息

Department of Urology, Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland.

出版信息

Eur Urol. 2007 Nov;52(5):1448-54. doi: 10.1016/j.eururo.2007.05.012. Epub 2007 May 25.

DOI:10.1016/j.eururo.2007.05.012
PMID:17544206
Abstract

OBJECTIVES

To assess the degree of hormonal abnormalities in testicular cancer survivors and the effect of these changes on patients' quality of life.

METHODS

Men with complete remission of testicular cancer for over 2 yr were eligible. Patients completed the State-Trait Anxiety Inventory (STAI), the Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory (BDI), the International Index of Erectile Function (IIEF), and the Sexual Functioning Questionnaire (SFQ), and rated their physical and psychological well-being, quality of life, and relationship with their partner. Levels of the hormones testosterone, estradiol, thyreotropin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin were determined. Relationships between hormone levels and questionnaire results were assessed.

RESULTS

A total of 326 men were tested, of whom 269 were treated with platinum-based chemotherapy. The most common endocrine abnormalities were above-normal gonadotropin levels (LH, 55%, and FSH, 49% of cases) and lowered testosterone (15%). Twenty-seven percent (STAI) and 28% (HADS) of the patients had abnormal anxiety levels, while the depression rate was 15% (BDI) and 18% (HADS); 40% of patients had erectile dysfunction. Linear regression analysis excluding the influence of age showed higher depression levels in the BDI among patients with elevated LH (p=0.010) or FSH (p=0.017). Patients with above-normal LH showed increased sexual problems in the SFQ (p=0.030). Elevated gonadotropins correlated with deteriorated physical well-being (p=0.028). Men with abnormal estradiol were more prone to erectile dysfunction (p=0.009).

CONCLUSIONS

Hormonal abnormalities have a negative impact on the quality of life of testicular cancer survivors.

摘要

目的

评估睾丸癌幸存者激素异常的程度以及这些变化对患者生活质量的影响。

方法

睾丸癌完全缓解超过2年的男性符合条件。患者完成状态-特质焦虑量表(STAI)、医院焦虑抑郁量表(HADS)、贝克抑郁量表(BDI)、国际勃起功能指数(IIEF)和性功能问卷(SFQ),并对他们的身心健康、生活质量以及与伴侣的关系进行评分。测定睾酮、雌二醇、促甲状腺激素、促卵泡激素(FSH)、促黄体生成素(LH)和催乳素的激素水平。评估激素水平与问卷结果之间的关系。

结果

共对326名男性进行了检测,其中269名接受了铂类化疗。最常见的内分泌异常是促性腺激素水平高于正常(LH为55%的病例,FSH为49%的病例)以及睾酮降低(15%)。27%(STAI)和28%(HADS)的患者焦虑水平异常,而抑郁率为15%(BDI)和18%(HADS);40%的患者存在勃起功能障碍。排除年龄影响的线性回归分析显示,LH(p=0.010)或FSH(p=0.017)升高的患者在BDI中的抑郁水平更高。LH高于正常的患者在SFQ中显示出性问题增加(p=0.030)。促性腺激素升高与身体健康恶化相关(p=0.028)。雌二醇异常的男性更容易出现勃起功能障碍(p=0.009)。

结论

激素异常对睾丸癌幸存者的生活质量有负面影响。

相似文献

1
The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era.顺铂时代睾丸癌幸存者的生活质量与激素紊乱
Eur Urol. 2007 Nov;52(5):1448-54. doi: 10.1016/j.eururo.2007.05.012. Epub 2007 May 25.
2
Editorial comment on: The quality of life and hormonal disturbances in testicular cancer survivors in cisplatin era.关于《顺铂时代睾丸癌幸存者的生活质量和激素紊乱》的编辑评论
Eur Urol. 2007 Nov;52(5):1454-5. doi: 10.1016/j.eururo.2007.05.013.
3
Sexual dysfunctions and blood hormonal profile in men with focal epilepsy.局灶性癫痫男性患者的性功能障碍与血液激素水平
Epilepsia. 2006 Dec;47(12):2135-40. doi: 10.1111/j.1528-1167.2006.00851.x.
4
[Evaluation of quality of life, anxiety and depression in testicular cancer patients during chemotherapy and after anticancer treatment].[睾丸癌患者化疗期间及抗癌治疗后的生活质量、焦虑和抑郁评估]
Psychiatr Pol. 2010 Jul-Aug;44(4):543-56.
5
Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.睾丸癌幸存者的情绪障碍与性腺功能减退症、雄激素受体多态性和治疗方式有关。
J Affect Disord. 2010 May;122(3):260-6. doi: 10.1016/j.jad.2009.06.035. Epub 2009 Aug 4.
6
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids.长期接触阿片类药物的癌症男性幸存者中的症状性性腺功能减退。
Cancer. 2004 Feb 15;100(4):851-8. doi: 10.1002/cncr.20028.
7
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.转移性睾丸癌长期幸存者的代谢综合征与激素水平紊乱
J Clin Oncol. 2005 Jun 1;23(16):3718-25. doi: 10.1200/JCO.2005.02.176. Epub 2005 Feb 28.
8
Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function.睾丸癌的治疗:对垂体-性腺轴及性功能的影响。
Urology. 2005 Aug;66(2):402-6. doi: 10.1016/j.urology.2005.03.050.
9
Quality of life in survivors of testicular cancer.睾丸癌幸存者的生活质量。
Urol Oncol. 2005 May-Jun;23(3):193-200. doi: 10.1016/j.urolonc.2005.03.004.
10
Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.睾丸癌幸存者的雄激素缺乏症状与性问题相关,但与血清睾酮或治疗无关。
Urology. 2009 Oct;74(4):825-9. doi: 10.1016/j.urology.2009.03.051. Epub 2009 Jul 8.

引用本文的文献

1
Tracking and analysis of testicular cancer burden in adolescents and young adults globally in Asia and in China: 1990-2021 epidemiological trends.1990 - 2021年全球、亚洲及中国青少年和青年睾丸癌负担的追踪与分析:流行病学趋势
Transl Androl Urol. 2025 Jul 30;14(7):2075-2088. doi: 10.21037/tau-2025-394. Epub 2025 Jul 25.
2
Micronized purified flavonoid fraction (daflon) improves sexual function by modulating NF-kB /NO/cGMP and steroidogenic signaling in cisplatin-treated male Wistar rats.微粉化纯化黄酮类成分(达弗隆)通过调节顺铂处理的雄性Wistar大鼠中的NF-κB/NO/cGMP和类固醇生成信号来改善性功能。
Biochem Biophys Rep. 2025 Jul 10;43:102144. doi: 10.1016/j.bbrep.2025.102144. eCollection 2025 Sep.
3
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM).
癌症护理中的性健康:来自意大利医学肿瘤学会(AIOM)的叙述性综述与立场声明
ESMO Open. 2025 Jun;10(6):105311. doi: 10.1016/j.esmoop.2025.105311. Epub 2025 Jun 11.
4
Global burden and trends of testicular cancer in adolescents and young adults from 1990 to 2021, with predictions to 2035.1990年至2021年青少年和青年睾丸癌的全球负担及趋势,并预测至2035年。
Sci Rep. 2024 Dec 30;14(1):31787. doi: 10.1038/s41598-024-82897-4.
5
The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism.化疗方案对男性生殖细胞肿瘤患者原发性性腺功能减退症发展的影响。
Sci Rep. 2024 Nov 15;14(1):28141. doi: 10.1038/s41598-024-78765-w.
6
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study.以目标为导向的情绪调节治疗(GET)在青年睾丸癌幸存者中的应用:一项随机先导研究。
Ann Behav Med. 2023 Aug 21;57(9):777-786. doi: 10.1093/abm/kaad010.
7
Changes in male sexuality after urologic cancer: a narrative review.泌尿科癌症患者的男性性功能变化:叙述性综述。
Int Braz J Urol. 2023 Mar-Apr;49(2):175-183. doi: 10.1590/S1677-5538.IBJU.2023.9901.
8
Epidemiology of Male Hypogonadism.男性性腺功能减退症的流行病学。
Endocrinol Metab Clin North Am. 2022 Mar;51(1):1-27. doi: 10.1016/j.ecl.2021.11.016. Epub 2022 Feb 8.
9
Semen and serum platinum levels in cisplatin-treated survivors of germ cell cancer.顺铂治疗生殖细胞癌幸存者的精液和血清铂水平。
Cancer Med. 2022 Feb;11(3):728-734. doi: 10.1002/cam4.4480. Epub 2021 Dec 17.
10
Erectile dysfunction among testicular cancer survivors: A systematic review and meta-analysis.睾丸癌幸存者中的勃起功能障碍:一项系统评价和荟萃分析。
Heliyon. 2021 Jul 3;7(7):e07479. doi: 10.1016/j.heliyon.2021.e07479. eCollection 2021 Jul.